✦ LIBER ✦

Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability

✍ Scribed by Sachin Surade; Tom L. Blundell

Book ID: 113531187
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 816 KB
Volume: 19
Category: Article
ISSN: 1074-5521
DOI: 10.1016/j.chembiol.2011.12.013

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Methods and Principles in Medicinal Che

[Methods and Principles in Medicinal Chemistry] Epigenetic Targets in Drug Discovery Volume 42 || Structural Biology of Epigenetic Targets

✍ Sippl, Wolfgang; Jung, Manfred 📂 Article 📅 2009 🏛 Wiley ⚖ 889 KB

Systems Biology in Drug Discovery and De

Systems Biology in Drug Discovery and Development (Young/Systems Bio in Drug Discovery) || Applications of Systems Biology Approaches to Target Identification and Validation in Drug Discovery

✍ Young, Daniel L.; Michelson, Seth 📂 Article 📅 2011 🏛 John Wiley & Sons, Inc. ⚖ 214 KB

Genomics and the discovery of new drug t

Genomics and the discovery of new drug targets

✍ David A Jones; Frank A Fitzpatrick 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 84 KB

Molecular medicine and genomics technologies are inseparable for defining new molecular targets. cDNA databases and elementary informatic tools provide instantaneous glimpses of gene families or tissue-restricted expression patterns as a means of new target identification. In addition, cDNA microarr

Structure-Based Discovery of Ligands Tar

Structure-Based Discovery of Ligands Targeted to the RNA Double Helix †

✍ Chen, Qi; Shafer, Richard H.; Kuntz, Irwin D. 📂 Article 📅 1997 🏛 American Chemical Society 🌐 English ⚖ 155 KB

The discovery and validation of new drug

The discovery and validation of new drug targets in cancer

✍ Sara A Courtneidge; Greg D Plowman 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 672 KB

Advances in our understanding of the signal transduction pathways involved in cellular growth control have provided several new strategies for cancer therapy. Recent advances now make it possible to develop selective inhibitors targeting genomic instability, the growth, survival, and invasion of the

The role of structure-based ligand desig

The role of structure-based ligand design and molecular modelling in drug discovery

✍ Tollenaere, J. P. 📂 Article 📅 1996 🏛 Springer 🌐 Dutch ⚖ 839 KB